Expanded Access to Provide Copanlisib for Patients With Cancer Who Are Experiencing a Positive Response, as Determined by Their Doctors
Clinical trial NCT06238583 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT06238583
- Sponsor
- Bayer
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.